行情

CRMD

CRMD

CORMEDIX
AMEX

实时行情|Nasdaq Last Sale

4.100
-0.150
-3.53%
盘后: 4.120 +0.02 +0.49% 17:57 08/11 EDT
开盘
4.250
昨收
4.250
最高
4.280
最低
4.020
成交量
41.81万
成交额
--
52周最高
8.64
52周最低
2.160
市值
1.25亿
市盈率(TTM)
-2.2818
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测CRMD价格均价为11.00,最高价位12.00,最低价为10.00。

EPS

CRMD 新闻

更多
CorMedix's (CRMD) CEO Khoso Baluch on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 23小时前
CorMedix (CRMD) Reports Q2 Loss, Misses Revenue Estimates
Zacks · 1天前
CorMedix Inc. Reports Second Quarter and Six Month 2020 Financial Results and Provides Business Update
GlobeNewswire · 1天前
Cormedix Q2 EPS $(0.14), Inline, Sales $16.44M Up From $35.27K YoY
Cormedix (AMEX:CRMD) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 366.67 percent decrease over losses of $(0.03) per share from the same period last year. The
Benzinga · 1天前
Elliott Investment Management L.P. Reports Stake Of 5.8% Of CorMedix Inc As Of July 30, 2020
-Reuters
Reuters · 1天前
Cormedix's Earnings: A Preview
Benzinga · 4天前
CorMedix Inc. to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 10
GlobeNewswire · 08/03 21:05
CorMedix slumps after pricing equity offering
CorMedix (NYSEMKT:CRMD) is down 22% premarket on increased volume in reaction to its public offering of ~4.4M common shares at $4.50 per share. Underwriter
seekingalpha · 07/28 18:26

所属板块

制药
-0.40%
制药与医学研究
-0.89%

热门股票

代码
价格
涨跌幅

CRMD 简况

CorMedix Inc. is a commercial pharmaceutical and medical device company. The Company in-licenses, develops and commercializes prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company has in-licensed the rights to develop and commercialize its product candidate, CRMD003 (Neutrolin), which addresses market opportunities in the instances in which a central venous catheter is used, such as hemodialysis, intensive care units, oncology, and patients receiving total parenteral nutrition, intravenous (IV) hydration, and/or IV medications. Neutrolin is an anti-infective solution for the prevention of catheter-related infections and thrombosis in the central venous catheter markets, such as dialysis, critical care and oncology. Neutrolin is a broad-spectrum antimicrobial/antifungal and anticoagulant combination that is active against common microbes, including antibiotic-resistant strains, and may prevent biofilm formation.
展开

微牛提供CorMedix Inc.(AMEX-CRMD)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CRMD股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CRMD股票基本功能。